DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Nakamura M, Kondo H, Mori T. , et al.
Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis.
Hepatology 2007;
45 (01) 118-127
We do not assume any responsibility for the contents of the web pages of other providers.